Browsing: million

An insider at MBX Biosciences, Inc. (NASDAQ:MBX), a pharmaceutical company specializing in therapeutic treatments, recently made a significant purchase of…

NEA 17, a major shareholder in MBX Biosciences, Inc. (NASDAQ:MBX), recently made a significant purchase of the company’s stock. The…

MBX Biosciences, Inc. (NASDAQ:MBX) executives, specializing in pharmaceutical preparations, have recently purchased a significant amount of the company’s common stock.…

In a recent transaction, executives from OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, and OrbiMed Genesis GP LLC collectively…

In a recent market development, Patrick J. Heron, a director and significant shareholder at MBX Biosciences, Inc. (NASDAQ:MBX), demonstrated strong…

MBX Biosciences, Inc.’s director, Aynechi Tiba, recently made a significant investment in the company by acquiring 750,000 shares of common…

Palantir Technologies Inc. CEO Alexander Karp has recently sold a substantial amount of company stock, totaling over $300 million in…

(Reuters) – Berkshire Hathaway, the investment firm led by billionaire Warren Buffett, has once again reduced its stake in Bank…

By Jane Smith (Reuters) – In a significant development, the three largest U.S. drug distributors have agreed to a $300…

Financial Firm B. Riley Plans Sale of Majority Stake in Great American Group According to a report by Bloomberg, distressed…